Testicular xenografts: a novel approach to study cytotoxic damage in juvenile primate testis

Kirsi Jahnukainen1, Jens Ehmcke, Stefan Schlatt

  • 1Center for Research in Reproductive Physiology, Department of Cell Biology and Physiology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA. Kirsi.Jahnukainen@kbh.ki.se

Cancer Research
|April 6, 2006
PubMed

Insights

Childhood chemotherapy

Area of Science:

  • Reproductive biology
  • Developmental biology
  • Toxicology

Background:

  • Chemotherapy's impact on juvenile testes is poorly understood.
  • Developing primate testis models are needed for research.
  • Xenografting offers a way to study testicular development without patient risk.

Purpose of the Study:

  • To establish and validate a xenograft model using juvenile monkey testicular tissue.
  • To investigate the effects of busulfan, a chemotherapeutic agent, on developing primate testes.
  • To assess germ cell damage and spermatogenesis progression in response to cytotoxic treatment.

Main Methods:

  • Juvenile monkey testicular tissue was xenografted into castrated nude mice.
  • Grafts were treated with busulfan or a vehicle control.
  • Graft size, number, and histological analysis of germ cell populations were performed.

Main Results:

  • Busulfan significantly reduced germ cell numbers and depleted type B spermatogonia and later stages.
  • Type A pale spermatogonia decreased, but type A dark spermatogonia remained unaffected.
  • Spermatogenesis progressed to pachytene spermatocytes at busulfan treatment and round spermatids in controls.

Conclusions:

  • Xenografting of monkey testicular tissue is a viable model for studying cytotoxic effects.
  • Busulfan selectively damages differentiating spermatogonia, with some spermatocytes surviving.
  • This model aids in understanding chemotherapy-induced testicular damage in primates.

Related Concept Videos